Coughlin Timothy sold TVTX
May 15, 2026 · Form 4 insider transaction
Coughlin Timothy sold 3,250 shares of Travere Therapeutics, Inc. at $43.49 per share, a transaction worth $141.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,250
Price
$43.49
Total value
$141.3K
InsiderCoughlin Timothy
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 15, 2026
Filing dateMay 19, 2026
Shares owned after52,250
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on November 19, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.